VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 187 filers reported holding VAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,549,292 | -11.8% | 756,165 | -13.6% | 1.55% | +1.7% |
Q2 2023 | $43,697,500 | +128.6% | 875,000 | +71.6% | 1.53% | +140.7% |
Q1 2023 | $19,114,800 | -75.3% | 510,000 | -68.4% | 0.63% | -62.2% |
Q4 2022 | $77,458,430 | +413.3% | 1,615,400 | +156.9% | 1.68% | +446.6% |
Q3 2022 | $15,089,000 | – | 628,700 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |